Drug intelligence / Profile preview

SPION-PEG-550

Development stage
Preclinical
Lead developer
Tanta University
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intraperitoneal, Intravenous
01

Overview

SPION-PEG-550 is an experimental nanoparticle formulation consisting of a superparamagnetic iron oxide core (SPION) functionalized with polyethylene glycol (PEG) chains of approximately 550 Daltons in molecular weight. This specific PEGylation is designed to enhance the biocompatibility, stability, and systemic circulation time of the iron oxide core. While SPIONs have traditionally been utilized as contrast agents in magnetic resonance imaging (MRI), SPION-PEG-550 is being investigated for therapeutic applications, particularly in the treatment of obesity. Preclinical research suggests that these nanoparticles can exert anti-obesity effects by inducing mitochondrial biogenesis and promoting the browning of white adipose tissue, thereby increasing metabolic activity and energy expenditure. The iron oxide component may also influence cellular signaling pathways related to lipid metabolism and thermogenesis.

Other names
PEGylated superparamagnetic iron oxide nanoparticlesPEG-550 coated SPIONsPEG550 coated SPIONsPEG 550 coated SPIONsPolyethylene glycol 550-coated superparamagnetic iron oxide nanoparticles
02

Targets

UCP1 (Uncoupling protein 1)PPARGC1A (Peroxisome proliferator–activated receptor gamma coactivator 1-alpha)

Beyond the preview

Go deeper on SPION-PEG-550.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPION-PEG-550.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call